Ironwood Pharmaceuticals Statistics
Total Valuation
IRWD has a market cap or net worth of $177.05 million. The enterprise value is $682.87 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, before market open.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
IRWD has 162.43 million shares outstanding. The number of shares has increased by 2.18% in one year.
Current Share Class | 162.43M |
Shares Outstanding | 162.43M |
Shares Change (YoY) | +2.18% |
Shares Change (QoQ) | +9.85% |
Owned by Insiders (%) | 2.36% |
Owned by Institutions (%) | 71.73% |
Float | 118.57M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 5.07 |
PS Ratio | 0.57 |
Forward PS | 0.62 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | 5.91 |
P/OCF Ratio | 5.90 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 7.29, with an EV/FCF ratio of 22.81.
EV / Earnings | n/a |
EV / Sales | 2.21 |
EV / EBITDA | 7.29 |
EV / EBIT | 7.44 |
EV / FCF | 22.81 |
Financial Position
The company has a current ratio of 0.82
Current Ratio | 0.82 |
Quick Ratio | 0.77 |
Debt / Equity | n/a |
Debt / EBITDA | 6.15 |
Debt / FCF | 20.00 |
Interest Coverage | 2.64 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | 15.53% |
Return on Invested Capital (ROIC) | 18.83% |
Return on Capital Employed (ROCE) | 83.08% |
Revenue Per Employee | $1.22M |
Profits Per Employee | -$31,166 |
Employee Count | 253 |
Asset Turnover | 0.84 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, IRWD has paid $50.80 million in taxes.
Income Tax | 50.80M |
Effective Tax Rate | 118.37% |
Stock Price Statistics
The stock price has decreased by -74.29% in the last 52 weeks. The beta is 0.33, so IRWD's price volatility has been lower than the market average.
Beta (5Y) | 0.33 |
52-Week Price Change | -74.29% |
50-Day Moving Average | 0.75 |
200-Day Moving Average | 2.02 |
Relative Strength Index (RSI) | 69.52 |
Average Volume (20 Days) | 1,492,158 |
Short Selling Information
The latest short interest is 5.38 million, so 3.31% of the outstanding shares have been sold short.
Short Interest | 5.38M |
Short Previous Month | 6.53M |
Short % of Shares Out | 3.31% |
Short % of Float | 4.54% |
Short Ratio (days to cover) | 4.12 |
Income Statement
In the last 12 months, IRWD had revenue of $308.52 million and -$7.89 million in losses. Loss per share was -$0.05.
Revenue | 308.52M |
Gross Profit | 306.37M |
Operating Income | 91.74M |
Pretax Income | 88.16M |
Net Income | -7.89M |
EBITDA | 93.68M |
EBIT | 91.74M |
Loss Per Share | -$0.05 |
Full Income Statement Balance Sheet
The company has $92.85 million in cash and $598.67 million in debt, giving a net cash position of -$505.82 million or -$3.11 per share.
Cash & Cash Equivalents | 92.85M |
Total Debt | 598.67M |
Net Cash | -505.82M |
Net Cash Per Share | -$3.11 |
Equity (Book Value) | -308.16M |
Book Value Per Share | -1.90 |
Working Capital | -40.77M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $29.99 million and capital expenditures -$49,000, giving a free cash flow of $29.94 million.
Operating Cash Flow | 29.99M |
Capital Expenditures | -49,000 |
Free Cash Flow | 29.94M |
FCF Per Share | $0.18 |
Full Cash Flow Statement Margins
Gross margin is 99.30%, with operating and profit margins of 29.73% and -2.56%.
Gross Margin | 99.30% |
Operating Margin | 29.73% |
Pretax Margin | 13.91% |
Profit Margin | -2.56% |
EBITDA Margin | 30.36% |
EBIT Margin | 29.73% |
FCF Margin | 9.70% |
Dividends & Yields
IRWD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.18% |
Shareholder Yield | -2.18% |
Earnings Yield | -4.45% |
FCF Yield | 16.91% |
Dividend Details Analyst Forecast
The average price target for IRWD is $4.94, which is 353.21% higher than the current price. The consensus rating is "Buy".
Price Target | $4.94 |
Price Target Difference | 353.21% |
Analyst Consensus | Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | -14.99% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
IRWD has an Altman Z-Score of -4.88 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -4.88 |
Piotroski F-Score | 6 |